Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 13/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.60 |
| ▸ | MEN1 | O00255 | 10/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.60 |
| ▸ | GAA | P10253 | 10/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.60 |
| ▸ | NPC1 | O15118 | 7/20 | 0.60 |
| ▸ | RAB9A | P51151 | 7/20 | 0.60 |
| ▸ | HPGD | P15428 | 6/20 | 0.60 |
| ▸ | TP53 | P04637 | 4/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | APP | P05067 | 1/20 | 0.60 |
| ▸ | SNCA | P37840 | 1/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.60 |
| ▸ | RELA | Q04206 | 1/20 | 0.60 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 6/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1663309 | 0.84 | MAPKAPK2 (0.49) | MAPTKDM4EMEN1KMT2AGAA | |
| SCHEMBL725354 | 0.79 | PLAU (0.66) | MAPTKDM4EMEN1KMT2AGAA | |
| SCHEMBL1748354 | 0.79 | ALDH1A1 (0.66) | MAPTKDM4EMEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL6621844 | 0.78 | PLAU (0.63) | MAPTKDM4EMEN1KMT2AGAA | |
| SCHEMBL1925827 | 0.76 | MAPT (0.76) | MAPTKDM4EMEN1KMT2AGAA | |
| SCHEMBL4376248 | 0.76 | PLAU (0.61) | KDM4EGAAALDH1A1HPGDPOLB | |
| SCHEMBL172884 | 0.76 | MEN1 (0.59) | MAPTKDM4EMEN1KMT2AGAA | |
| SCHEMBL482021 | 0.76 | ALDH1A1 (0.56) | MAPTKDM4EALDH1A1RAB9ALMNA | |
| SCHEMBL1747975 | 0.76 | ALPL (0.56) | ALDH1A1HTR3EHTR3BHTR3ABACE1 | |
| SCHEMBL827359 | 0.76 | KMT2A (0.58) | MAPTKDM4EKMT2AGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2024-02-29 | — | — | US | disclosed |
| US-11786520-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11311531-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2022-04-26 | — | — | US | disclosed |
| US-20210290615-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2021-09-23 | — | — | US | disclosed |
| US-20200261441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2020-08-20 | — | — | US | disclosed |
| US-20200246328-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2020-08-06 | — | — | US | disclosed |
| US-10624885-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2020-04-21 | — | — | US | disclosed |
| US-20180214441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2018-08-02 | — | — | US | disclosed |
| US-9622991-B2 | Hematopoietic growth factor mimetic small molecule compounds and their uses | LIGAND PHARMACEUTICALS INC. (US) | 2017-04-18 | — | — | US | disclosed |
| CN-102656141-B | Micromolecular compound of simulation hemopoieticgrowth factor and uses thereof | LIGAND PHARMACEUTICALS INC. (US) | 2016-04-06 | — | — | CN | disclosed |
| US-20150252043-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2015-09-10 | — | — | US | disclosed |
| US-20140243324-A1 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2014-08-28 | — | — | US | disclosed |
| EP-2642994-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | Ligand Pharmaceuticals Incorporated (US) | 2013-10-02 | — | — | EP | disclosed |
| CN-103282034-A | Use of hematopoietic growth factor mimetics | LIGAND PHARM INC | 2013-09-04 | — | — | CN | disclosed |
| US-20120295904-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | LIGAND PHARMACEUTICALS INC. (US) | 2012-11-22 | — | — | US | disclosed |
| EP-2488486-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | Ligand Pharmaceuticals Inc. (US) | 2012-08-22 | — | — | EP | disclosed |
| WO-2012068406-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2011046954-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | LIGAND PHARMACEUTICALS INC. (US) | 2011-04-21 | — | — | WO | disclosed |
| US-5347008-A | Thio(cyclo) alkanepolycarboxylic acids containing heterocyclic substituents | CIBA-GEIGY CORPORATION (US) | 1994-09-13 | — | — | US | disclosed |
| US-5152929-A | Corrosion inhibitors for water systems | CIBA-GEIGY CORPORATION (US) | 1992-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786520-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | MAPT 4399/4885KDM4E 2442/4885MEN1 4042/4885 |
| US-20140243324-A1 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | HGF, EPOR, MPL | MAPT 4622/4885KDM4E 3484/4885MEN1 1370/4885 |
| US-11311531-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | MAPT 4449/4885KDM4E 2129/4885MEN1 4053/4885 |
| US-20200246328-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | MAPT 4449/4885KDM4E 2129/4885MEN1 4053/4885 |
| US-10624885-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | MAPT 4449/4885KDM4E 2129/4885MEN1 4053/4885 |
| US-20210290615-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | MAPT 4399/4885KDM4E 2442/4885MEN1 4042/4885 |
| US-20150252043-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | MPL, CSF3R, HGF | MAPT 4411/4885KDM4E 1944/4885MEN1 1395/4885 |
| US-20120295904-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | MPL, CSF3R, HGF | MAPT 4411/4885KDM4E 1944/4885MEN1 1395/4885 |
| US-20180214441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | MAPT 4449/4885KDM4E 2129/4885MEN1 4053/4885 |
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | MAPT 4399/4885KDM4E 2442/4885MEN1 4042/4885 |
| US-20200261441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | MAPT 4449/4885KDM4E 2129/4885MEN1 4053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.